APRI Announces First Patient Enrolled In Phase 2a Trial For RayVa; Keryx Announces Issuance Of New U.S. Patent For Auryxia
December 04, 2014 at 20:25 PM EST
A look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014, including APRI, KERX, ALDX, CCXI
